Academic Journal

The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study

التفاصيل البيبلوغرافية
العنوان: The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study
المؤلفون: Hodgson, Carol L., Higgins, Alisa M., Bailey, Michael J., Mather, Anne M., Beach, Lisa, Bellomo, Rinaldo, Bissett, Bernie, Boden, Ianthe J., Bradley, Scott, Burrell, Aidan, Cooper, D. James, Fulcher, Bentley J., Haines, Kimberley J., Hopkins, Jack, Jones, Alice Y. M., Lane, Stuart, Lawrence, Drew, van der Lee, Lisa, Liacos, Jennifer, Linke, Natalie J., Gomes, Lonni Marques, Nickels, Marc, Ntoumenopoulos, George, Myles, Paul S., Patman, Shane, Paton, Michelle, Pound, Gemma, Rai, Sumeet, Rix, Alana, Rollinson, Thomas C., Sivasuthan, Janani, Tipping, Claire J., Thomas, Peter, Trapani, Tony, Udy, Andrew A., Whitehead, Christina, Hodgson, Isabelle T., Anderson, Shannah, Neto, Ary Serpa, Burgess, Nicola, Hearn, Kirsty, Brewster, David, Waanders, Alyssa, Simpson, Shannon, de Silva, Yasmin, Lang, Jenna, Burleigh, Sarah, Killer, Elisha, Wang, Michael, O’Connor, Lauren
المساهمون: National Health and Medical Research Council
المصدر: Critical Care ; volume 25, issue 1 ; ISSN 1364-8535
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2021
الوصف: Background There are few reports of new functional impairment following critical illness from COVID-19. We aimed to describe the incidence of death or new disability, functional impairment and changes in health-related quality of life of patients after COVID-19 critical illness at 6 months. Methods In a nationally representative, multicenter, prospective cohort study of COVID-19 critical illness, we determined the prevalence of death or new disability at 6 months, the primary outcome. We measured mortality, new disability and return to work with changes in the World Health Organization Disability Assessment Schedule 2.0 12L (WHODAS) and health status with the EQ5D-5L TM . Results Of 274 eligible patients, 212 were enrolled from 30 hospitals. The median age was 61 (51–70) years, and 124 (58.5%) patients were male. At 6 months, 43/160 (26.9%) patients died and 42/108 (38.9%) responding survivors reported new disability. Compared to pre-illness, the WHODAS percentage score worsened (mean difference (MD), 10.40% [95% CI 7.06–13.77]; p < 0.001). Thirteen (11.4%) survivors had not returned to work due to poor health. There was a decrease in the EQ-5D-5L TM utility score (MD, − 0.19 [− 0.28 to − 0.10]; p < 0.001). At 6 months, 82 of 115 (71.3%) patients reported persistent symptoms. The independent predictors of death or new disability were higher severity of illness and increased frailty. Conclusions At six months after COVID-19 critical illness, death and new disability was substantial. Over a third of survivors had new disability, which was widespread across all areas of functioning. Clinical trial registration NCT04401254 May 26, 2020.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1186/s13054-021-03794-0
DOI: 10.1186/s13054-021-03794-0.pdf
DOI: 10.1186/s13054-021-03794-0/fulltext.html
الاتاحة: http://dx.doi.org/10.1186/s13054-021-03794-0
https://link.springer.com/content/pdf/10.1186/s13054-021-03794-0.pdf
https://link.springer.com/article/10.1186/s13054-021-03794-0/fulltext.html
Rights: https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0
رقم الانضمام: edsbas.862A4214
قاعدة البيانات: BASE
الوصف
DOI:10.1186/s13054-021-03794-0